PDB 5my8

PDB Information

PDB5MY8
MethodX-RAY DIFFRACTION
Host OrganismEscherichia coli BL21(DE3)
Gene SourceHomo sapiens
Primary Citation
Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease.
Batson, J., Toop, H.D., Redondo, C., Babaei-Jadidi, R., Chaikuad, A., Wearmouth, S.F., Gibbons, B., Allen, C., Tallant, C., Zhang, J., Du, C., Hancox, J.C., Hawtrey, T., Da Rocha, J., Griffith, R., Knapp, S., Bates, D.O., Morris, J.C.
ACS Chem. Biol.
HeaderTransferase
Released2017-01-25
Resolution1.700
CATH Insert Date14 May, 2017

PDB Images (4)

PDB Prints

PDB Chains (1)

Chain ID Date inserted into CATH CATH Status
A 15 May, 2017 Chopped

CATH Domains (2)

Domain ID Date inserted into CATH Superfamily CATH Status
5my8A01 06 Nov, 2017 3.30.200.20 Assigned
5my8A02 06 Nov, 2017 1.10.510.10 Assigned

UniProtKB Entries (1)

Accession Gene ID Taxon Description
Q96SB4 SRPK1_HUMAN Homo sapiens SRSF protein kinase 1
CATH-Gene3D is a Global Biodata Core Resource Learn more...